Publications by authors named "Peter Trebilcock"

Article Synopsis
  • * A study tested 125 patient samples against 126 anticancer drugs, finding strong correlations between specific genomic alterations and effective drug responses, indicating potential targeted treatments.
  • * The integration of high-throughput screening (HTS) with molecular profiling can enhance precision medicine by identifying effective biomarkers and drug combinations for high-risk pediatric cancer patients.
View Article and Find Full Text PDF

Biomarkers which better match anticancer drugs with cancer driver genes hold the promise of improved clinical responses and cure rates. We developed a precision medicine platform of rapid high-throughput drug screening (HTS) and patient-derived xenografting (PDX) of primary tumor tissue, and evaluated its potential for treatment identification among 56 consecutively enrolled high-risk pediatric cancer patients, compared with conventional molecular genomics and transcriptomics. Drug hits were seen in the majority of HTS and PDX screens, which identified therapeutic options for 10 patients for whom no targetable molecular lesions could be found.

View Article and Find Full Text PDF

Diffuse intrinsic pontine glioma (DIPG) is an aggressive and incurable childhood brain tumor for which new treatments are needed. CBL0137 is an anti-cancer compound developed from quinacrine that targets facilitates chromatin transcription (FACT), a chromatin remodeling complex involved in transcription, replication, and DNA repair. We show that CBL0137 displays profound cytotoxic activity against a panel of patient-derived DIPG cultures by restoring tumor suppressor TP53 and Rb activity.

View Article and Find Full Text PDF